Literature DB >> 15962223

Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections.

Robert B Tesh1, Marina Siirin, Hilda Guzman, Amelia P A Travassos da Rosa, Xiaoyan Wu, Tao Duan, Hao Lei, Marcio R Nunes, Shu-Yuan Xiao.   

Abstract

Golden hamsters (Mesocricetus auratus) experimentally infected with West Nile virus (WNV) developed chronic renal infection and persistent shedding of virus in urine for up to 8 months, despite initial rapid clearance of virus from blood and the timely appearance of high levels of specific neutralizing antibodies. Infectious WNV could be recovered by direct culture of their urine and by cocultivation of kidney tissue for up to 247 days after initial infection. Only moderate histopathologic changes were observed in the kidneys or brain of the chronically infected hamsters, although WNV antigen was readily detected by immunohistochemistry within epithelium, interstitial cells, and macrophages in the distal renal tubules. Comparison of WNV isolates from serial urine samples from individual hamsters over several months indicated that the virus underwent both genetic and phenotypic changes during persistent infection. These findings are similar to previous reports of persistent infection with tickborne encephalitis and Modoc viruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962223     DOI: 10.1086/431153

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  66 in total

1.  Vγ4+ T cells regulate host immune response to West Nile virus infection.

Authors:  Thomas Welte; Judith Aronson; Bin Gong; Aparna Rachamallu; Nicole Mendell; Robert Tesh; Slobodan Paessler; Willi K Born; Rebecca L O'Brien; Tian Wang
Journal:  FEMS Immunol Med Microbiol       Date:  2011-11

Review 2.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

Review 3.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

Review 4.  Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends.

Authors:  Goro Kuno; Gwong-Jen J Chang
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 5.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 6.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

7.  Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication.

Authors:  Jeffrey E McLean; Aleksandra Wudzinska; Emmanuel Datan; Daniela Quaglino; Zahra Zakeri
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

Review 8.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Persistent infection with West Nile virus years after initial infection.

Authors:  Kristy Murray; Christopher Walker; Emily Herrington; Jessica A Lewis; Joseph McCormick; David W C Beasley; Robert B Tesh; Susan Fisher-Hoch
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

10.  Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Authors:  Niraj C Patel; Steven J Halvorson; Vojtech Sroller; Amy S Arrington; Connie Wong; E O'Brian Smith; Regis A Vilchez; Janet S Butel
Journal:  Virology       Date:  2009-01-31       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.